Literature DB >> 27468220

Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.

Pegah Golabi1, Cameron T Locklear1, Patrick Austin1, Sophie Afdhal1, Melinda Byrns1, Lynn Gerber1, Zobair M Younossi1.   

Abstract

AIM: To investigate the efficacy of exercise interventions on hepatic fat mobilization in non-alcoholic fatty liver disease (NAFLD) patients.
METHODS: Ovid-Medline, PubMed, EMBASE and Cochrane database were searched for randomized trials and prospective cohort studies in adults aged ≥ 18 which investigated the effects of at least 8 wk of exercise only or combination with diet on NAFLD from 2010 to 2016. The search terms used to identify articles, in which exercise was clearly described by type, duration, intensity and frequency were: "NASH", "NAFLD", "non-alcoholic steatohepatitis", "non-alcoholic fatty liver disease", "fat", "steatosis", "diet", "exercise", "MR spectroscopy" and "liver biopsy". NAFLD diagnosis, as well as the outcome measures, was confirmed by either hydrogen-magnetic resonance spectroscopy (H-MRS) or biopsy. Trials that included dietary interventions along with exercise were accepted if they met all criteria.
RESULTS: Eight studies met selection criteria (6 with exercise only, 2 with diet and exercise with a total of 433 adult participants). Training interventions ranged between 8 and 48 wk in duration with a prescribed exercise frequency of 3 to 7 d per week, at intensities between 45% and 75% of VO2 peak. The most commonly used imaging modality was H-MRS and one study utilized biopsy. The effect of intervention on fat mobilization was 30.2% in the exercise only group and 49.8% in diet and exercise group. There was no difference between aerobic and resistance exercise intervention, although only one study compared the two interventions. The beneficial effects of exercise on intrahepatic triglyceride (IHTG) were seen even in the absence of significant weight loss. Although combining an exercise program with dietary interventions augmented the reduction in IHTG, as well as improved measures of glucose control and/or insulin sensitivity, exercise only significantly decreased hepatic lipid contents.
CONCLUSION: Prescribed exercise in subjects with NAFLD reduces IHTG independent of dietary intervention. Diet and exercise was more effective than exercise alone in reducing IHTG.

Entities:  

Keywords:  Diet; Exercise; Fat mobilization; Lifestyle modification; Non-alcoholic fatty liver disease

Mesh:

Substances:

Year:  2016        PMID: 27468220      PMCID: PMC4945989          DOI: 10.3748/wjg.v22.i27.6318

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  41 in total

1.  American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease.

Authors: 
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

Review 2.  Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Shelley E Keating; Daniel A Hackett; Jacob George; Nathan A Johnson
Journal:  J Hepatol       Date:  2012-03-10       Impact factor: 25.083

Review 3.  Non-alcoholic fatty liver disease: what has changed in the treatment since the beginning?

Authors:  Bülent Baran; Filiz Akyüz
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 4.  Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

Authors:  Christian Thoma; Christopher P Day; Michael I Trenell
Journal:  J Hepatol       Date:  2011-07-01       Impact factor: 25.083

5.  Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.

Authors:  Alita Mishra; Zobair M Younossi
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

Review 6.  Exercise and the liver: implications for therapy in fatty liver disorders.

Authors:  Nathan A Johnson; Shelley E Keating; Jacob George
Journal:  Semin Liver Dis       Date:  2012-03-13       Impact factor: 6.115

7.  American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise.

Authors:  Carol Ewing Garber; Bryan Blissmer; Michael R Deschenes; Barry A Franklin; Michael J Lamonte; I-Min Lee; David C Nieman; David P Swain
Journal:  Med Sci Sports Exerc       Date:  2011-07       Impact factor: 5.411

Review 8.  Non alcoholic fatty liver: epidemiology and natural history.

Authors:  Mario Masarone; Alessandro Federico; Ludovico Abenavoli; Carmela Loguercio; Marcello Persico
Journal:  Rev Recent Clin Trials       Date:  2014

Review 9.  Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.

Authors:  Alessandro Federico; Claudio Zulli; Ilario de Sio; Anna Del Prete; Marcello Dallio; Mario Masarone; Carmela Loguercio
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

10.  Exercise training reverses endothelial dysfunction in nonalcoholic fatty liver disease.

Authors:  Christopher J A Pugh; Victoria S Spring; Graham J Kemp; Paul Richardson; Fariba Shojaee-Moradie; A Margot Umpleby; Daniel J Green; N Timothy Cable; Helen Jones; Daniel J Cuthbertson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-11-01       Impact factor: 4.733

View more
  39 in total

1.  Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin.

Authors:  Wenqi Yang; Ling Liu; Yuan Wei; Chunlu Fang; Shujing Liu; Fu Zhou; Yaping Li; Ge Zhao; Ziyi Guo; Yuan Luo; Liangming Li
Journal:  Lab Invest       Date:  2020-12-02       Impact factor: 5.662

2.  The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Mohammed Eslam; Shiv K Sarin; Vincent Wai-Sun Wong; Jian-Gao Fan; Takumi Kawaguchi; Sang Hoon Ahn; Ming-Hua Zheng; Gamal Shiha; Yusuf Yilmaz; Rino Gani; Shahinul Alam; Yock Young Dan; Jia-Horng Kao; Saeed Hamid; Ian Homer Cua; Wah-Kheong Chan; Diana Payawal; Soek-Siam Tan; Tawesak Tanwandee; Leon A Adams; Manoj Kumar; Masao Omata; Jacob George
Journal:  Hepatol Int       Date:  2020-10-01       Impact factor: 6.047

3.  [Effect of Hugan Qingzhi tablets on AMPK pathway activation and NF-κB-p65 protein expression in the liver of rats with nonalcoholic fatty liver disease].

Authors:  Xiao-Rui Yao; Fan Xia; Wai-Jiao Tang; Ben-Jie Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-01-20

Review 4.  Nonalcoholic fatty liver disease: lifestyle and quality of life.

Authors:  Ilias Vachliotis; Antonis Goulas; Paraskevi Papaioannidou; Stergios A Polyzos
Journal:  Hormones (Athens)       Date:  2021-12-01       Impact factor: 2.885

5.  What's new in non-alcoholic fatty liver disease?

Authors:  Jessica Spiers; James Hallimond Brindley; Wenhao Li; William Alazawi
Journal:  Frontline Gastroenterol       Date:  2022-05-31

Review 6.  The Effects of Physical Exercise on Fatty Liver Disease.

Authors:  Dirk J van der Windt; Vikas Sud; Hongji Zhang; Allan Tsung; Hai Huang
Journal:  Gene Expr       Date:  2017-12-06

Review 7.  Molecular mechanisms of nonalcoholic fatty liver disease: Potential role for 12-lipoxygenase.

Authors:  Niharika Samala; Sarah A Tersey; Naga Chalasani; Ryan M Anderson; Raghavendra G Mirmira
Journal:  J Diabetes Complications       Date:  2017-07-31       Impact factor: 2.852

8.  Objectively measured sedentary time, physical activity and liver enzyme elevations in US Hispanics/Latinos.

Authors:  Jun Li; Simin Hua; Guo-Chong Chen; Garrett Strizich; Mark H Kuniholm; Zhilei Shan; Gregory A Talavera; Sheila F Castañeda; Marc D Gellman; Jianwen Cai; Scott J Cotler; Xuehong Zhang; Frank B Hu; Robert Kaplan; Carmen R Isasi; Qibin Qi
Journal:  Liver Int       Date:  2020-05-25       Impact factor: 5.828

Review 9.  Diet and exercise in NAFLD/NASH: Beyond the obvious.

Authors:  Georg Semmler; Christian Datz; Thomas Reiberger; Michael Trauner
Journal:  Liver Int       Date:  2021-08-21       Impact factor: 8.754

Review 10.  Nonalcoholic Fatty Liver Disease after Liver Transplant.

Authors:  Akshay Shetty; Fanny Giron; Mukul K Divatia; Muhammad I Ahmad; Sudha Kodali; David Victor
Journal:  J Clin Transl Hepatol       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.